New Immunotherapy Drugs: Iparomlimab And Tuvonralimab Injection Show Promising Results In Clinical Trials
February 25, 2025 – In an exciting advancement in immunotherapy, the combination of Iparomlimab and…
News
Janagliflozin (Ganagliflozin Proline Tablets): Mechanism of Action and Clinical Insights
Janagliflozin, also known as Ganagliflozin Proline Tablets, marketed under the brand name HuiYouJing, is an…
Ongericimab Injection (JUNSHID®) Approved For Use In China
On October 11, 2024, Junshi Biosciences announced that its self-developed recombinant humanized anti-PCSK9 monoclonal antibody…
Rilonacept Injection: A Breakthrough Treatment For Auto-Inflammatory Disorders
In the fight against severe and chronic auto-inflammatory diseases, Rilonacept Injection has emerged as a…
Mirvetuximab Soravtansine-Gynx Injection: A New Hope For Ovarian Cancer Patients
February 2025 – In a groundbreaking advancement in the treatment of platinum-resistant ovarian cancer, the…
Sacituzumab Tirumotecan For Injection: A Breakthrough In Cancer Treatment
February 2025 — In a significant advancement in the treatment of certain aggressive cancers, Sacituzumab…
What Is The New Drug For Lung Cancer In 2024?
In 2024, several new lung cancer treatments, including Unecritinib Fumarate Capsules, Tarlatamab, Zenocutuzumab, Lazertinib and…
Loncastuximab Tesirine-Lpyl: A New Hope For Patients With Relapsed Or Refractory Large B-Cell Lymphoma
February 2025 — In a significant breakthrough for cancer treatment, Loncastuximab Tesirine-lpyl (brand name Zynlonta)…
Lunsumio(Mosunetuzumab): A New Era In B-Cell Lymphoma Treatment
In the rapidly advancing world of cancer treatment, Lunsumio(Mosunetuzumab) has emerged as a promising new…
Zolbetuximab-Clzb For Injection: A New Hope In Cancer Treatment
In the ever-evolving landscape of oncology, a promising new drug, Zolbetuximab-Clzb for Injection, has made…